Galectin-3 in Ambulatory Patients with Heart Failure: Results from the HF-ACTION Study

BACKGROUND: Galectin-3 is a soluble ß-galactoside-binding lectin released by activated cardiac macrophages. Elevated levels of galectin-3 have been found to be associated with adverse outcomes in patients with heart failure. We evaluated the association between galectin-3 and long-term clinical outc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Felker, G. Michael, Fiuzat, Mona, Shaw, Linda K., Clare, Robert, Whellan, David J., Bettari, Luca, Shirolkar, Shailesh C., Donahue, Mark, Kitzman, Dalane W., Zannad, Faiez, Piña, Ileana L., O’Connor, Christopher M.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3261343/
https://ncbi.nlm.nih.gov/pubmed/22016505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.111.963637
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars